|
Jul 28
|
Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025
|
|
Jul 28
|
Unlocking Oncology’s Future: 3 Trending Cancer Biotech Stocks with ‘Strong Buy’ Ratings
|
|
Jul 28
|
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
|
|
Jul 25
|
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Gain 1.6% for Week
|
|
Jul 24
|
European Penny Stocks Worth Watching In July 2025
|
|
Jul 23
|
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
|
|
Jul 22
|
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
|
|
Jul 3
|
European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading
|
|
Jul 1
|
European Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading
|
|
Jun 26
|
Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025
|
|
Jun 26
|
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
|
|
Jun 25
|
European Penny Stocks To Watch In June 2025
|
|
May 12
|
Cellectis Reports Financial Results for the First Quarter 2025
|
|
May 7
|
Monthly information on share capital and company voting rights
|
|
May 6
|
Cellectis to Report First Quarter Financial Results on May 12, 2025
|
|
Mar 13
|
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update
|
|
Feb 24
|
Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025
|